RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Transmedics Group Stock

Transmedics Group EBIT 2024

Transmedics Group EBIT

47.48 M USD

Ticker

TMDX

ISIN

US89377M1099

WKN

A2PH5P

In 2024, Transmedics Group's EBIT was 47.48 M USD, a 9,690.1% increase from the 485,000 USD EBIT recorded in the previous year.

The Transmedics Group EBIT history

YEAREBIT (undefined USD)
2028e167.43
2027e145.76
2026e129.02
2025e80.74
2024e47.48
20230.49
2022-31.44
2021-39.43
2020-26.38
2019-29.6
2018-20.24
2017-20.43
2016-22.99

Transmedics Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Transmedics Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Transmedics Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Transmedics Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Transmedics Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Transmedics Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Transmedics Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Transmedics Group’s growth potential.

Transmedics Group Revenue, EBIT and net profit per share

DateTransmedics Group RevenueTransmedics Group EBITTransmedics Group Net Income
2028e1.01 B undefined167.43 M undefined170.47 M undefined
2027e848.95 M undefined145.76 M undefined133.84 M undefined
2026e673.52 M undefined129.02 M undefined89.16 M undefined
2025e560.91 M undefined80.74 M undefined56.5 M undefined
2024e443.18 M undefined47.48 M undefined36.86 M undefined
2023241.62 M undefined485,000 undefined-25.03 M undefined
202293.46 M undefined-31.44 M undefined-36.23 M undefined
202130.26 M undefined-39.43 M undefined-44.22 M undefined
202025.64 M undefined-26.38 M undefined-28.75 M undefined
201923.6 M undefined-29.6 M undefined-33.55 M undefined
201813.02 M undefined-20.24 M undefined-23.76 M undefined
20177.69 M undefined-20.43 M undefined-20.82 M undefined
20166.21 M undefined-22.99 M undefined-24.07 M undefined

Transmedics Group stock margins

The Transmedics Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Transmedics Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Transmedics Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Transmedics Group's sales revenue. A higher gross margin percentage indicates that the Transmedics Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Transmedics Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Transmedics Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Transmedics Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Transmedics Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Transmedics Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Transmedics Group Margin History

Transmedics Group Gross marginTransmedics Group Profit marginTransmedics Group EBIT marginTransmedics Group Profit margin
2028e63.77 %16.54 %16.84 %
2027e63.77 %17.17 %15.77 %
2026e63.77 %19.16 %13.24 %
2025e63.77 %14.39 %10.07 %
2024e63.77 %10.71 %8.32 %
202363.77 %0.2 %-10.36 %
202269.84 %-33.64 %-38.77 %
202169.93 %-130.3 %-146.13 %
202064.9 %-102.89 %-112.13 %
201958.73 %-125.42 %-142.16 %
201844.01 %-155.45 %-182.49 %
201727.83 %-265.67 %-270.74 %
201612.4 %-370.21 %-387.6 %

Transmedics Group Aktienanalyse

What does Transmedics Group do?

Transmedics Group Inc is a company dedicated to the development and manufacturing of medical devices for organ transplantation. The company was founded in 1998 and is headquartered in Andover, Massachusetts, USA. Transmedics' business model is based on offering a unique and innovative technology for organ preservation during transport from donor to recipient. The patented Organ Care System (OCS) platform includes a range of state-of-the-art medical devices specifically designed for organ transport. Transmedics' Organ Care System includes three main devices: OCS Heart, OCS Lung, and OCS Liver. Each device is tailored for organ preparation and transport, providing individualized support based on the specific requirements of each organ and different transfer protocols. The OCS technology uses hypothermic (cold) perfusion to preserve the organ during transport. By continuously monitoring and supporting the organ's physiological functions, the OCS system can improve the survival rate of donor organs while reducing the time spent outside the body. Transmedics also offers comprehensive services, including the availability of OCS devices and qualified personnel to provide support throughout the transplantation process. Transmedics' customers include leading transplant centers and hospitals worldwide. The company works closely with these customers to ensure that its OCS devices meet the specific requirements of each transplantation program and help them achieve more successful transplantations. Transmedics' history is marked by a passion for improving transplantation medicine and saving lives through the provision of advanced technologies and solutions. The company has made significant progress in recent years and has experienced strong growth in all areas. Transmedics has also received a number of awards and recognition for its commitment to improving transplantation medicine. For example, in 2020, the company received the Red Herring Top 100 Global Award and was recognized for the seventh consecutive year as one of the fastest-growing companies by Deloitte. Overall, Transmedics is a leading provider of innovative medical devices for transplantation medicine. Through its organic technology and comprehensive service, the company supports transplant centers and hospitals worldwide in performing more successful transplantations and saving patients' lives. Transmedics Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Transmedics Group's EBIT

Transmedics Group's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Transmedics Group's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Transmedics Group's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Transmedics Group’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Transmedics Group stock

How much did Transmedics Group achieve in EBIT for the current year?

In the current year, Transmedics Group has achieved an EBIT of 47.48 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Transmedics Group.

How has the EBIT of Transmedics Group developed in recent years?

The EBIT of Transmedics Group has increased by 9,690.103% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Transmedics Group?

The EBIT of Transmedics Group is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Transmedics Group pay?

Over the past 12 months, Transmedics Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Transmedics Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Transmedics Group?

The current dividend yield of Transmedics Group is .

When does Transmedics Group pay dividends?

Transmedics Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Transmedics Group?

Transmedics Group paid dividends every year for the past 0 years.

What is the dividend of Transmedics Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Transmedics Group located?

Transmedics Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Transmedics Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Transmedics Group from 11/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did Transmedics Group pay the last dividend?

The last dividend was paid out on 11/6/2024.

What was the dividend of Transmedics Group in the year 2023?

In the year 2023, Transmedics Group distributed 0 USD as dividends.

In which currency does Transmedics Group pay out the dividend?

The dividends of Transmedics Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Transmedics Group

Our stock analysis for Transmedics Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Transmedics Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.